Novel Drug Boosts Responses to BCG Bladder Cancer Treatment
Anktiva boosted responses to BCG treatment without affecting quality of life, research showed.
Sharing at a Cancer Support Group
At a cancer support group at my church, we sit together and share our cancer stories.
Novel Drug Regimen Shows Significant Benefits in Acute Myeloid Leukemia
Newly diagnosed patients with FLT3-mutated acute myeloid leukemia showed improvements after receiving crenolanib plus chemotherapy in a recent study.
Living With My Chronic Cancer: Small Lymphocytic Lymphoma
I've been living with small lymphocytic lymphoma for 14 years now, but it has taught be some valuable lessons about life.
Lower Dose of Nausea, Vomiting Drug Controls Chemo Symptoms
A 2.5-mg dose of olanzapine provided similar control of nausea/vomiting as the standard 10-milligram dose in patients with solid tumors receiving chemotherapy.
Digital Tool Reduces Burden, Improves Mood for Cancer Hospice Caregivers
A digital tool for caregivers of patients with cancer in hospice care significantly reduced some of the caregiver burden while improving their mood.
NCCN Guidelines Give Framework for Childhood Neuroblastoma Treatment
New guidelines provide a framework for pediatric neuroblastoma treatment — as well as conversations families should have with their oncology teams.
Just Do It! Staying Fit During and After Cancer
I lived by Nike's motto, "Just do it!" and worked to gain my muscle back after cancer.
Super Bowl Player Reflects on Cancer Diagnosis, Congressman Returns to Work After Myeloma Treatment and More
From the San Francisco 49ers’ Trent Williams looking back on his cancer experience to a Republican congressman returning to work after myeloma treatment, here’s what’s happening in the oncology space this week.
Blenrep Combo for Relapsed, Refractory Myeloma Improves Outcomes
Patients with relapsed or refractory multiple myeloma had lower progressive disease outcomes when receiving Blenrep with Velcade and dexamethasone, research found.
4-Drug Regimen Preferred for Presurgical Bladder Cancer, But Drug Shortage Ensues
Treatment for muscle-invasive bladder cancer called dose-dense MVAC did not improve survival compared with chemotherapy alone, although one drug in the combination faces a shortage.
What Are Biomarkers and How Are They Used in Kidney Cancer?
An expert said that he is optimistic about the future use of biomarkers in the kidney cancer space.
Dealing With Cancer’s Uncertainty
The anxiety of cancer will seemingly never go away.
Opdivo Plus Chemo Did Not Improve Progression in EGFR-Mutated NSCLC
Treatment with Opdivo (nivolumab) and chemotherapy did not significantly improve progression-free survival when compared with chemotherapy alone among some patients with EGFR-mutated metastatic non-small-cell lung cancer.
Blincyto Gets FDA Priority Review in B-Cell Acute Lymphoblastic Leukemia
The Food and Drug Administration granted a priority review to Blincyto for the treatment of early-stage CD19-positive B-cell acute lymphoblastic leukemia.
‘Striking’ Findings for Substance Use Disorders in Some Cancer Types
Substance use disorders, such as alcohol use disorder, were found to be more prevalent among survivors of specific cancer types, according to research.
Tagrisso After Chemoradiation Reduced Progression Risk in NSCLC
Treatment with Tagrisso after chemoradiation resulted in patients with EGFR-mutant stage 3 non-small cell lung cancer being nearly three times less likely to experience disease progression when compared with those treated with Imfinzi or subject to observation.
4 Tips for People Newly Diagnosed With Cancer
I felt like I had to come back to life after hearing the word “metastatic.”
FDA Fast Tracks ARV-471 for Metastatic Breast Cancer
The Food and Drug Administration granted a Fast Track designation to the novel drug, ARV-471 for patients with metastatic or locally advanced ER-positive, HER2-negative breast cancer.
Immune-Related Side Effects Associated With Improved Survival in NSCLC
The development of immune-related side effects is associated with improved overall survival among patients with metastatic non-small cell lung cancer (NSCLC) who receive immune checkpoint inhibitor therapy.
Breast Cancer Survivor Eases Anxiety Through a Mind-Body Program
As a survivor, Karen Gartland found that a mind-body program was helpful, as it taught her useful techniques for when her health anxiety spikes.
After Metastatic Breast Cancer Diagnosis, Advocate Empowers Patients
“We have to make it known to people that we are not just a patient,” said Michelle Anderson-Benjamin, CEO of the Fearless Warrior Project, who received a diagnosis of metastatic breast cancer in 2022.
Drug Combos May Help Lower Blood Pressure in Patients Taking Imbruvica
Certain antihypertensive medications may lower blood pressure in patients with blood cancer being treated with Imbruvica or other BTK inhibitors.
Bringing Lessons from Cancer to the Next Chapter
Cancer has taught me valuable lessons and now, I'm letting these lessons guide me.
FDA Grants Priority Review for Alecensa in Some ALK-Positive NSCLC
The FDA has granted Priority Review to oral ALK inhibitor Alecensa (alectinib) for patients with early-stage ALK-positive non-small cell lung cancer.
Country Singer Toby Keith Dies of Cancer
Country singer Toby Keith died Monday after receiving a stomach cancer diagnosis in 2022.
FDA Accepts Priority Review for Novel Synovial Sarcoma Drug
Patients with advanced synovial sarcoma may have a new therapy option if the novel drug, afami-cel, is approved by the FDA after the priority review.
King Charles III Receives Cancer Diagnosis
King Charles III received a diagnosis of cancer after a procedure for an enlarged prostate, although Buckingham Palace specified that the king does not have prostate cancer.
Why Do Breast Cancer Survivors Require Annual Prostheses Prescriptions?
After a recent fiasco while trying to order prostheses and bras, I have an important question I’d like answered.
Patient-Provider Conversations After a Bladder Cancer Diagnosis
There are a few conversations patients should have with their care teams after being diagnosed with bladder cancer — especially as new treatments become more available.
2 Commerce Drive Cranbury, NJ 08512